Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) Financial Performance & Income Statement Overview
Review Becton, Dickinson and Company (BDX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Becton, Dickinson and Company (BDX) Income Statement & Financial Overview
Review Becton, Dickinson and Company BDX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $5.27B | $5.17B | $5.44B | $4.99B |
| Cost of Revenue | $3.02B | $2.93B | $2.95B | $2.68B |
| Gross Profit | $2.26B | $2.23B | $2.49B | $2.31B |
| Gross Profit Ratio | $0.43 | $0.43 | $0.46 | $0.46 |
| R&D Expenses | $302.00M | $343.00M | $302.00M | $299.00M |
| SG&A Expenses | $1.27B | $1.32B | $1.26B | $1.20B |
| Operating Expenses | $1.71B | $1.78B | $1.86B | $1.59B |
| Total Costs & Expenses | $4.73B | $4.71B | $4.62B | $4.28B |
| Interest Income | $5.00M | $23.00M | $55.00M | $48.00M |
| Interest Expense | $151.00M | $155.00M | $155.00M | $137.00M |
| Depreciation & Amortization | $7.00M | $607.00M | $47.00M | $568.00M |
| EBITDA | $546.00M | $1.07B | $697.00M | $1.21B |
| EBITDA Ratio | $0.10 | $0.21 | $0.13 | $0.24 |
| Operating Income | $546.00M | $453.00M | $650.00M | $715.00M |
| Operating Income Ratio | $0.10 | $0.09 | $0.12 | $0.14 |
| Other Income/Expenses (Net) | -$183.00M | -$147.00M | -$136.00M | -$215.00M |
| Income Before Tax | $363.00M | $306.00M | $514.00M | $500.00M |
| Income Before Tax Ratio | $0.07 | $0.06 | $0.09 | $0.10 |
| Income Tax Expense | $55.00M | $3.00M | $114.00M | $13.00M |
| Net Income | $308.00M | $303.00M | $400.00M | $487.00M |
| Net Income Ratio | $0.06 | $0.06 | $0.07 | $0.10 |
| EPS | $1.07 | $1.05 | -$4.51 | $1.68 |
| Diluted EPS | $1.07 | $1.04 | -$4.49 | $1.68 |
| Weighted Avg Shares Outstanding | $288.41M | $289.50M | $289.61M | $289.56M |
| Weighted Avg Shares Outstanding (Diluted) | $289.19M | $290.39M | $290.60M | $290.25M |
Financial performance has remained strong, with revenue growing from $4.99B in Q3 2024 to $5.27B in Q2 2025. Gross profit continued to perform well, with margins at 43% in the latest quarter. Operating income reached $546.00M in Q2 2025, holding a steady 10% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $546.00M. Net income rose to $308.00M, keeping EPS at $1.07. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan